Research Analysts Set Expectations for PVLA FY2024 Earnings

Palvella Therapeutics (NASDAQ:PVLA) – Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for shares of Palvella Therapeutics in a research note issued on Wednesday, December 18th. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will post earnings of ($3.02) per share for the year. Cantor Fitzgerald has a “Overweight” rating on the stock.

Palvella Therapeutics Stock Performance

Palvella Therapeutics stock opened at $12.05 on Friday. Palvella Therapeutics has a 12 month low of $6.20 and a 12 month high of $22.32.

Insider Activity

In related news, Director George M. Jenkins purchased 4,000 shares of the stock in a transaction that occurred on Wednesday, December 18th. The stock was acquired at an average cost of $12.93 per share, with a total value of $51,720.00. Following the transaction, the director now owns 180,671 shares of the company’s stock, valued at $2,336,076.03. This represents a 2.26 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.